Loading clinical trials...
Loading clinical trials...
The Effectiveness of an Online Self-Delivered Death Anxiety Intervention: A Pilot Randomized Controlled Trial
The goal of this clinical trial is to examine the effectiveness of the online self-delivered death anxiety intervention developed by our team in the general population with a randomized controlled trial. The study will recruit 50 participants, with 25 randomized to the death anxiety intervention group and 25 randomized to the control group (waiting list). The online intervention on death anxiety consists of 4 phases that take about 2 hours in total. The primary outcome DAS (Death Anxiety Scale) and DABBS (Death Anxiety Beliefs and Behaviors Scale) will be administered on baseline, post-treatment, 1-week follow-up, and 2-week follow-up assessments.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
Peking University
Beijing, Beijing Municipality, China
Start Date
February 14, 2025
Primary Completion Date
April 4, 2025
Completion Date
April 4, 2025
Last Updated
March 16, 2026
47
ACTUAL participants
Online self-delivered death anxiety intervention
BEHAVIORAL
Waiting-List (WL) condition
BEHAVIORAL
Lead Sponsor
Peking University
Collaborators
NCT06810999
NCT06478446
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions